| Pharmaceutical active ingredients: |
| Spironolactone |
| Available forms, composition and doses of Nefurofan: |
| N / A |
| Nefurofan medical category: |
| Human:DiureticsMineralocorticoid (Aldosterone) receptor antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03DA01 - Spironolactone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nefrix | Hydrochlorothiazide | Unidentified Pharmaceutical Company |
| Nefrol | Hydrochlorothiazide | Unidentified Pharmaceutical Company |
| Nefrosul | Sulfachlorpyridazine | Unidentified Pharmaceutical Company |
| Nefrotest | Aminohippuric Acid | Unidentified Pharmaceutical Company |
| Neftin | Furazolidone | Unidentified Pharmaceutical Company |
| Negalip | Clofibrate | Unidentified Pharmaceutical Company |
| Negamicin | Framycetin | Unidentified Pharmaceutical Company |
| Negashunt | Coumaphos | Unidentified Pharmaceutical Company |
| Negasunt | Coumaphos | Unidentified Pharmaceutical Company |
| Nektrohan | Allopurinol | Unidentified Pharmaceutical Company |